Dr. Indrakant K. Singh

The significant issues with the currently available medications are drug toxicity and drug resistance. My main area of study interest is finding inhibitors/agonists that are target-specific, have low toxicity, and have strong effects. My laboratory’s research focuses on cancer (breast cancer and neuroblastoma) and rare genetic disorders (Fibrodysplasia Ossificans Progressiva). We use both in silico...
Read More